ApoE4 carriers treated with ACE inhibitors, have more diagnoses of Alzheimer’s Disease, as compared with those who did not have the treatment (28% versus 6%) or ApoE4 non-carriers treated with an ACE inhibitor (28% versus 10%).
Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele
Qiu WW, Lai A, Mon T, Mwamburi M, Taylor W, Rosenzweig J, Kowall N, Stern R, Zhu H, Steffens DC. Am J Geriatr Psychiatry. 2014 Feb;22(2):177-85.
RELATED ARTICLES
